OOIR: Observatory of International Research

Papers

(The H4-Index of Cellular & Molecular Immunology is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death	986
NLRP3 inflammasome activation and cell death	649
Tumor-infiltrating lymphocytes in the immunotherapy era	491
An update on the regulatory mechanisms of NLRP3 inflammasome activation	372
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity	267
Neutrophils in chronic inflammatory diseases	246
The blood–brain barrier in systemic infection and inflammation	244
Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases	224
Gut microbiome, liver immunology, and liver diseases	216
Dendritic cell migration in inflammation and immunity	210
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors	208
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids	201
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron	180
Metabolism of tissue macrophages in homeostasis and pathology	180
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells	178
Manganese salts function as potent adjuvants	157
SARS-CoV-2-specific T cells in infection and vaccination	134
Activation or exhaustion of CD8+ T cells in patients with COVID-19	131
SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy	130
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors	124
The cutting-edge progress of immune-checkpoint blockade in lung cancer	121
Tumor-associated myeloid cells: diversity and therapeutic targeting	120
Immunological mechanisms and therapeutic targets of fatty liver diseases	118
Dendritic cells in cancer immunology	118
Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients	113

Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response	111
Neutralizing antibodies for the prevention and treatment of COVID-19	99
SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation	98
Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment	93
Neutrophils in liver diseases: pathogenesis and therapeutic targets	90
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor	86
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection	86
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies	85
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods	84
Immunopathobiology and therapeutic targets related to cytokines in liver diseases	83
Impact of intracellular innate immune receptors on immunometabolism	82
T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant	82
Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm	79
Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia	78
Autoimmmune hepatitis	76
Microglia as hackers of the matrix: sculpting synapses and the extracellular space	75
Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis	74
The aryl hydrocarbon receptor and the gut–brain axis	73
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy	72
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice	71
IFNγ signaling integrity in colorectal cancer immunity and immunotherapy	71
T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals	69
The roles of microglia in viral encephalitis: from sensome to therapeutic targeting	68
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy	67
Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells	66
Protein N-myristoylation: functions and mechanisms in control of innate immunity	63
Protein synthesis, degradation, and energy metabolism in T cell immunity	61
Diet, lipids, and antitumor immunity	61
Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy	59
Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation	59
Biology and pathology of the uterine microenvironment and its natural killer cells	56